Figure 2.
Cumulative incidence of relapse in the subcohort for the 2 groups based on asparaginase truncation and enzyme activity. TruncatedorAEA-: 11.1% (95% CI, 6.9-15.4), nontruncatedandAEA+: 6.7% (95% CI, 4.7-8.6). ALL, acute lymphoblastic leukemia.

Cumulative incidence of relapse in the subcohort for the 2 groups based on asparaginase truncation and enzyme activity. TruncatedorAEA-: 11.1% (95% CI, 6.9-15.4), nontruncatedandAEA+: 6.7% (95% CI, 4.7-8.6). ALL, acute lymphoblastic leukemia.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal